Clincosm LogoSign in Get a demo

recurrent endometrial cancer

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Recurrent Endometrial Cancer, Metastatic Cancer Trial (ART0380)

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • (no location specified)
Apr 5, 2023

Recurrent Gynecological Cancer, Metastatic Cervical Cancer, Metastatic Ovarian Cancer Trial in Boston (Durvalumab, Tremelimumab,

Terminated
  • Recurrent Gynecological Cancer
  • +10 more
  • Boston, Massachusetts
    Martin King
Oct 4, 2022

Endometrial Cancer, Recurrent Endometrial Cancer Trial in United States (LY3023414)

Completed
  • Endometrial Cancer
  • Recurrent Endometrial Cancer
  • Basking Ridge, New Jersey
  • +5 more
Sep 13, 2022

Recurrent Endometrial Cancer, Solid Tumors Trial in Pittsburgh (pembrolizumab, Sitravatinib)

Recruiting
  • Recurrent Endometrial Cancer
  • Solid Tumors
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 12, 2022

Ovarian Cancer, Endometrial Cancer, Recurrent Ovarian Cancer Trial (BKM120, Nabpaclitaxel)

Withdrawn
  • Ovarian Cancer
  • +3 more
  • (no location specified)
Jul 27, 2022

Endometrial Cancer, Mismatch Repair-Proficient, Recurrent Endometrial Cancer Trial in Richmond (Lenvatinib, Pembrolizumab)

Recruiting
  • Endometrial Cancer
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University
Apr 5, 2022

Fallopian Tube Carcinoma, Recurrent Ovarian Cancer, Primary Peritoneal Carcinoma Trial in Columbus (Lenvatinib Mesylate,

Completed
  • Fallopian Tube Carcinoma
  • +3 more
  • Lenvatinib Mesylate
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 5, 2022

Recurrent Endometrial Cancer Trial in France (Olaparib, metformin, metronomic cyclophosphamide)

Completed
  • Recurrent Endometrial Cancer
  • Caen, France
  • +5 more
Dec 6, 2021

Recurrent Endometrial Cancer Trial (Pembrolizumab, Axitinib)

Withdrawn
  • Recurrent Endometrial Cancer
  • (no location specified)
Nov 4, 2020

Recurrent Endometrial Cancer Trial (Lapatinib and ixempra)

Unknown status
  • Recurrent Endometrial Cancer
  • Lapatinib and ixempra
  • (no location specified)
Oct 18, 2011